Polycystic Ovary Syndrome (PCOS) - Surgery

Surgical treatment is occasionally used for women with infertility caused by polycystic ovary syndrome (PCOS) who do not start ovulating after taking medicine. During surgery, ovarian function is improved by reducing the number of small cysts.

Surgery Choices

Ovarian wedge resection is the surgical removal of part of an ovary. This is done to help regulate menstrual cycles and start normal ovulation. It is rarely used now because of the possibility of damaging the ovary and creating scar tissue.
Laparoscopic ovarian drilling is a surgical treatment that can trigger ovulation in women with PCOS who have not responded to weight loss and fertility medicine. Electrocautery or a laser is used to destroy portions of the ovaries. Studies of women with PCOS have reported that ovarian drilling results in an 80% ovulation rate and a 50% pregnancy rate,¹¹ but other studies have shown less success. Younger women and those with a body mass index in the normal range are most likely to benefit from laparoscopic ovarian drilling.¹³

What To Think About

There is no known cure for PCOS. Surgery for PCOS may be recommended only if you have not responded to any other treatment for PCOS. Each woman will want to discuss the risks and benefits of this surgery with her doctor. Surgery is less likely to lead to multiple pregnancies than taking fertility medicines. It is not known how long the benefits from surgery will last. There is some concern that ovarian surgery can cause scar tissue, which can lead to pain or more fertility problems.

WebMD Medical Reference from Healthwise

Last Updated: January 23, 2008

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.

Polycystic Ovary Syndrome (PCOS) Topics

Bladder Control Problems?
Have a Life Less Interrupted

Important Safety Information | Prescribing Information

ENABLEX is a prescription medicine used in adults to treat the following symptoms due to a condition called overactive bladder:

· having a strong need to go to the bathroom right away (also called "urgency")
· leaks or wetting accidents (also called "urinary incontinence")
· having to go to the bathroom too often (also called "urinary frequency")

IMPORTANT SAFETY INFORMATION

You should not take once-daily ENABLEX if you have certain types of stomach problems, glaucoma, or have trouble emptying your bladder. Side effects of ENBLEX include blurred vision, and more commonly dry mouth, constipation, indigestion, and abdominal pain. Use caution when doing certain activities until you know how ENBALEX affects you.

As You Journey through Menopause, Vivelle-Dot Is By Your Side

VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.

INDICATION

Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.

IMPORTANT SAFETY INFORMATION

Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).

Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.

You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information for Vivelle-Dot.

Prescribing Information